Quote:
Originally Posted by jyl
China is the world’s largest supplier of pharma API and Chinese companies make hydroxychloroquine. It is a small molecule and probably pretty straightforward to make and to ramp up capacity. They don’t need to buy it from other countries. They might simply need to not export it.
|
There's a shortage of these drugs here. For all we know, there's one in China too given how many would be buying (and possibly hoarding) them.
Quote:
|
An actual randomized and blinded trial in China, albeit small (n=30), found no effectiveness of hydroxychloroquine vs control. A Wall Street analyst dug this up with some good research, the Chinese weren’t actively publicizing it. Larger trials are under way and will help answer the question. Both the small Chinese trials and the even smaller French not-actually-a-trial appear to have been in mild cases, as the control groups recovered fairly quickly too.
|
Given the study was published in some local Chinese medical journal, personally I don't put much weight on it.
Let's see what the larger trials say.